Get the Stockscreener App
0.8617
2.52%
-0.0223
Pre-market:
.85
-0.0117
-1.36%
Painreform Ltd stock is traded at $0.8617, with a volume of 39,954.
It is down -2.52% in the last 24 hours and down -33.20% over the past month.
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.
See More
Previous Close:
$0.884
Open:
$0.9
24h Volume:
39,954
Relative Volume:
0.09
Market Cap:
$1.73M
Revenue:
-
Net Income/Loss:
$-9.34M
P/E Ratio:
-0.1207
EPS:
-7.14
Net Cash Flow:
$-6.69M
1W Performance:
-7.34%
1M Performance:
-33.20%
6M Performance:
-55.81%
1Y Performance:
-79.29%
1-Day Range:
$0.8539
$0.94
1-Week Range:
$0.801
$0.94
52-Week Range:
$0.801
$16.63
Painreform Ltd Stock (PRFX) Company Profile
Compare PRFX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRFX
Painreform Ltd
|
0.8617 | 1.78M | 0 | -9.34M | -6.69M | -7.14 |
|
ZTS
Zoetis Inc
|
115.89 | 51.60B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.06 | 44.51B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.60 | 42.35B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
24.28 | 28.04B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
474.72 | 20.52B | 3.08B | 1.24B | 1.07B | 25.61 |
Painreform Ltd Stock (PRFX) Latest News
Is PainReform Ltd. stock recession proofQuarterly Profit Report & Advanced Swing Trade Entry Alerts - newser.com
Is PainReform Ltd. stock cheap at current valuationJuly 2025 Movers & Smart Swing Trading Techniques - newser.com
Will PainReform Ltd. bounce back from current supportEarnings Overview Summary & AI Driven Stock Movement Reports - newser.com
Price momentum metrics for PainReform Ltd. explainedMarket Performance Recap & Daily Technical Stock Forecast Reports - newser.com
PainReform Ltd. (PRFX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Is PainReform Ltd. stock attractive for long term wealth buildingWeekly Gains Report & Expert Approved Trade Ideas - newser.com
PainReform (NASDAQ:PRFX) Trading Down 1.3% – Here’s Why - Defense World
How PainReform Ltd. stock compares to industry benchmarksEarnings Risk Summary & Technical Buy Zone Confirmation - newser.com
Why PainReform Ltd. stock could rally in 2025Weekly Trade Review & Verified Technical Signals - newser.com
Best data tools to analyze PainReform Ltd. stockAnalyst Downgrade & Daily Price Action Insights - newser.com
symbol__ Stock Quote Price and Forecast - CNN
PainReform’s DeepSolar Advances AI Reporting Engine for Solar Assets - MSN
PainReform (PRFX) Unveils Automated Reporting Engine for Solar P - GuruFocus
PainReform’s DeepSolar Advances Development of its AI-Driven Automated Reporting Engine for Solar-Asset Analysis - The Manila Times
[6-K] PAINREFORM LTD. Current Report (Foreign Issuer) | PRFX SEC FilingForm 6-K - Stock Titan
PainReform’s DeepSolar Advances with NVIDIA Connect and Pilot Projects - MSN
Views of Wall Street’s Leading Experts on PainReform Ltd - setenews.com
Can PainReform Ltd. stock sustain market leadershipJuly 2025 Price Swings & Weekly High Momentum Picks - Fundação Cultural do Pará
Will PainReform Ltd. stock rally after Fed decisionsProduct Launch & Community Supported Trade Ideas - Fundação Cultural do Pará
Can PainReform Ltd. stock continue upward trendPortfolio Gains Summary & Reliable Price Breakout Signals - Fundação Cultural do Pará
PainReform Ltd. (PRFX) Stock: Surges by 8.10% Amid DeepSolar’s AI-Driven Solar Analytics Breakthrough - parameter.io
PRFX Stock Gains Momentum Amid Recent Developments - StocksToTrade
PainReform’s DeepSolar, Developing “DeepSolar Predict” within the NVIDIA Connect Program, Featured in The Market Link’s “Watchlist Interview” and Announces Progress Toward Pilot Projects - Sahm
Regression analysis insights on PainReform Ltd. performanceJuly 2025 Pullbacks & Reliable Breakout Forecasts - newser.com
Painreform Ltd Stock (PRFX) Financials Data
Revenue
Net Income
Cash Flow
EPS
6.17%
0.67%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):